Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
25 hedge funds and large institutions have $2.08M invested in Histogen Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
423% more capital invested
Capital invested by funds: $398K → $2.08M (+$1.69M)
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
32% more funds holding
Funds holding: 19 → 25 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$997K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$171K |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$92.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$78.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$56K |
| 2 |
Renaissance Technologies
New York
|
-$42K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.2K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | +$100 | +4 | +50% |
|
HSTO Hedge Fund Activity: Q1 2021 in Review
25 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2021, worth a combined $2.08M — up 423% from $398K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HSTO positions and 3 closed out — a net gain of 7 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, adding an estimated $997K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $56K sold.
- 25 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2021, up from 19 in Q4 2020.
- Funds reported $2.08M of Histogen Inc. Common Stock stock for Q1 2021, up 423% quarter-over-quarter.
- 10 funds opened new Histogen Inc. Common Stock positions in Q1 2021 and 3 closed out, a net change of +7 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2021 was BlackRock, an estimated $997K added.
- The largest Histogen Inc. Common Stock seller in Q1 2021 was Warberg Asset Management, an estimated $56K sold.
Based on aggregated 13F filings for Q1 2021.